GlassScriptPrepare for your visit
Eric F Glassy
Anatomic Pathology & Clinical Pathology · Rancho Dominguez, CA · NPI 1962455337
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$59,337.15
in general payments reported to CMS, 2019-2025 · $7,692 in 2025
The $7,692 reported for 2025 was more than what 95% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Who reported paying
General payments only, top 6 by amount.
- Leica Microsystems INC. $38,193.50
- Roche Diagnostics Corporation $7,686.66
- Merck Sharp & Dohme LLC $6,027.21
- E.R. Squibb & Sons, L.L.C. $4,374.36
- Astrazeneca Pharmaceuticals LP $1,713.26
- Ventana Medical Systems, INC. $1,250.00
Drugs and devices associated with these payments
Hydromark Breast Biopsy Site Marker Enhertu Keytruda Virtuoso System For Ihc Ayvakit Lynparza
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Eric Glassy listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/817660/eric-f-glassy